Coordinating Access to Obtain ZOLINZA

Similar documents
Welcome to OPEN DOORS

Getting Started on. (iloprost) Inhalation Solution VENTAVIS

Abiraterone Acetate (Zytiga )

Cobimetinib (Cotellic ) ( koe-bi-me-ti-nib )

Etoposide (VePesid ) ( e-toe-poe-side )

Save up to $4,000 a year?!

Name: Date of Birth: Phone: ( ) Gender: Mailing Address: City: State: Zip: Social Security Number:

Welcome to Pinnacle Chiropractic Spine and Sports Center

PO Box , Charlotte, NC Phone: (877) Fax: (877)

Welcome to Pinnacle Chiropractic Spine and Sports Center

Date of Birth: Phone: ( ) Gender: M F. City: State: Zip:

PATIENT INFORMATION SHEET:

EMPOWERING YOU a guide for caregivers. Tom D. EMPLICITI caregiver I ll always provide help, love, and support

Last Name First Middle. Mailing Address. City State Zip Phone. Date of Birth Age Soc. Sec# Cell. Employer Work Phone

Columbia Gorge Heart Clinic 1108 June St. Appointment date/time Hood River, OR fax Physician

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PAZOPANIB. Patient s first names.

Are you at risk of blood clots?

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM DOCETAXEL + PREDNISOLONE. Patient s first names

PATIENT INFORMATION. Address: Sex: City: State: address: Cell Phone: Home Phone: Work Phone: address: Cell Phone:

TREATMENT JOURNAL. Helping you stay on track SELECT IMPORTANT SAFETY INFORMATION

Harvoni for the treatment of Hepatitis C

Preventing hospital-acquired blood clots

Infusion Treatment A Patient s Guide

Oral Ibrutinib (single agent)

Your Anesthesiologist, Anesthesia and Pain Control

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

WITHOUT YOUR WRITTEN CONSENT, WE CAN NOT SPEAK TO ANYONE REGARDING YOUR MEDICAL CARE due to privacy laws. You have the right to list anyone you

Whipple Procedure (Pancreaticoduodenectomy)

New Patient Registration Form NJR_NP_F100

Your Anesthesiologist, Anesthesia and Pain Control

Day Surgery at Toronto General Hospital

About Your Colectomy

VIEKIRA PAK and VIEKIRA PAK-RBV *

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION

Enhanced Recovery After. Colorectal Surgery. Your Path to Healing

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

ANTICOAGULATION MANAGEMENT SERVICE PATIENT AND FAMILY EDUCATION

UW MEDICINE PATIENT EDUCATION. Angiography: Radiofrequency Ablation to Treat Solid Tumor. What to expect. What is radiofrequency ablation?

Pancreaticoduodenectomy enhanced recovery programme (PD ERP) Information for patients

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE CONTINUOUS INFUSION

PATIENT INFORMATION INSURANCE INFORMATION

Fax: Do not mail the forms!

Cyclophosphamide INFUSION Infusion 4 Plus

Deep Vein Thrombosis (DVT) - Blood Clots

PLEASE FILL OUT FORM BELOW AND THEN FAX BACK TO: ADDITIONALLY, PLEASE BRING FORM WITH YOU ON THE DAY OF YOUR SCHEDULED APPOINTMENT.

Emergency Care for Blood and Marrow Transplant Patients

Radical cystectomy enhanced recovery plan. Information for patients

Enhanced Recovery Programme for total hip and knee replacement Orthopaedic Department Patient Information Leaflet

Date of Birth: Phone: ( ) Gender: M F. City: State: ZIP:

T & A (Tonsillectomy and Adenoidectomy)

Abbvie 3D for the treatment of Hepatitis C Genotype 1

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Statement of Financial Responsibility

Laparoscopy. Women's Health Unit. Patient Information Leaflet

Surgical Treatment for Cancer of the Oesophagus

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 + RITUXIMAB

Welcome to the Southeastern Urology Associates meridianemr Patient Portal

Health Home Flow Hypothetical Patient Scenario

Dear New Patient: Sincerely, The Scheduling Staff

Blood clot prevention. A guide for patients and carers

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM PEGYLATED LIPOSOMAL DOXORUBICIN (CAELYX)

Methylprednisolone and Cyclophosphamide for lung fibrosis Information for patients

Care of Your Peripherally Inserted Central Catheter

YOUR GUIDE TO PATIENT SUPPORT

Patient Communication Request

CarePartners Nursing Care Plan Anticoagulant Therapy

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Patient Information Varicose Vein Surgery Dr Marek Garbowski. Varicose Veins

Pediatric New Patient Form

PATIENT REGISTRATION FORM

Thank you for downloading this patient assistance document from NeedyMeds. We hope this program will help you get the medicine you need.

Tube Feeding at Home A Guidebook for Patients and Caregivers

UW MEDICINE PATIENT EDUCATION. How to prepare and what to expect DRAFT. What is an IVC filter?

Radiofrequency Ablation to Treat Solid Tumors

Patient information. Breast Reconstruction TRAM Breast Services Directorate PIF 102 V5

Patient Registration. City, State & Zip Code Date of Birth Age. Occupation: Family Physician: Married Single Other Spouse's Name

DAILY ACTIVITIES (Q1)

Patient Diary. Enhanced Recovery After Surgery (ERAS) Total Knee Replacement. Helping patients get better sooner after surgery.

A Guide to Your Hospital Stay When Having Gynecology Surgery

MEMBER HANDBOOK. Health Net HMO for Raytheon members

Major Oral Surgery: Composite Resection with Free Flap

Preparing for surgery

COLON & RECTAL SURGERY, INC.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FMD. Patient s first names.

General information about radiotherapy

Enhanced recovery after oesophagogastric surgery (EROS) Patient information and advice

Cesarean Birth (C-Section)

Welcome to MDLIVE. consultmdlive.com /7/365 access to U.S. board-certified doctors. Request a consultation

Caring for Patients at Risk for Aspiration

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Hickman line insertion and caring for your line

Recognizing and Reporting Acute Change of Condition

Transcription:

ACT Now: 1-866-363-6379 Coordinating Access to Obtain ZOLINZA Reimbursement Support Services Patient Assistance BEFORE YOU LEAVE, please have your physician s office fax your prescription for ZOLINZA and completed enrollment form to the ACT program at 1-866-363-6389.

ACT Now: 1-866-363-6379 Clearing the Way for Quality Care Merck & Co., Inc., knows that healthcare reimbursement sometimes can make it difficult to access the medications that patients need. To ease the process, we have created the ACT program to help those patients who have been prescribed ZOLINZA (vorinostat), as well as their caregivers.

What Is the ACT Program for ZOLINZA (vorinostat)? ACT is a 3-part program specifically designed to help patients who have been prescribed ZOLINZA. Obtaining ZOLINZA Because ZOLINZA will not be stocked routinely at pharmacies, the ACT program will arrange to have ZOLINZA delivered to your preferred pharmacy. Reimbursement Support Services A free program that helps you and your physician s office answer questions related to insurance coverage for ZOLINZA. Patient Assistance for Eligible Patients A service that provides ZOLINZA free of charge to eligible patients. How to Contact ACT Call 1-866-363-6379 from 8 AM to 8 PM ET, Monday through Friday, to reach a Program Specialist. This specially trained representative will work with your insurance company and your pharmacy to ensure that you receive your ZOLINZA as quickly as possible. You will receive personalized assistance during the entire process. More information about the ACT program is available at zolinza.com. 1

ACT Now: 1-866-363-6379 Obtaining ZOLINZA (vorinostat) Once you have been prescribed ZOLINZA, the ACT program will help by arranging to have ZOLINZA delivered to your preferred pharmacy quickly and conveniently. STEP 1: Your physician prescribes ZOLINZA. STEP 2: You, your caregiver, or your healthcare provider completes the enrollment form and calls the ACT program at 1-866-363-6379 to begin the enrollment process. STEP 3: You or your healthcare provider sends the enrollment form and the prescription for ZOLINZA to the ACT program. STEP 4: The ACT program works with your insurance company and your pharmacy to ensure that ZOLINZA is delivered to your pharmacy as soon as possible.* STEP 5: A Program Specialist will follow up with you to ensure that you received your prescription. The ACT program also can provide educational materials relevant to treatment as well as helpful refill reminders. *ZOLINZA will not be stocked routinely at your local pharmacy. 2

Reimbursement Support Services for Patients ACT provides personalized support and patient advocacy with respect to individual reimbursement issues throughout the process. ACT Program Specialists are available from 8 AM to 8 PM ET, Monday through Friday, at 1-866-363-6379. Services Provided Dedicated, personalized support Complete investigation of insurance benefits, including information about your coverage and out-of-pocket costs Answers to questions about insurance coverage Collaboration with you and your physician to resolve issues related to payments, reimbursements, payment denials, and appeals Help with the Prior Authorization and Medical Necessity processes Comprehensive searches for alternate reimbursement resources (for example, state and federal assistance programs) and enrollment assistance for qualified patients Assessment of your qualification for patient assistance Although this program provides help with individual reimbursement problems, we cannot guarantee either coverage for or a specific reimbursement rate for ZOLINZA. If you do not qualify for coverage, the Program Specialist can help you apply for patient assistance. 3

ACT Now: 1-866-363-6379 Reimbursement Support Services for Patients Contacting ACT for Reimbursement Support Services Dedicated Program Specialists are available from 8 AM to 8 PM ET, Monday through Friday, at 1-866-363-6379. If you are calling about an insurance question, please be ready to give the following information: your name, address, date of birth, and Social Security number; and your insurance policy number, name of policyholder, and group number. Your personal identifying information will be available to RxCrossroads, the administrator of the program, but will not be disclosed to anyone else, except as necessary to administer the program or as required by law. 4

Patient Assistance for Eligible Patients An ACT Program Specialist will help you apply for the Patient Assistance program, which provides ZOLINZA free of charge to eligible patients without insurance coverage.* Eligible patients must complete the appropriate enrollment form and send it and the prescription for ZOLINZA to the ACT program. Enrollment forms are in this brochure and at zolinza.com. Benefits of the Program Convenience: You can apply in 1 of 3 ways phone, fax, or mail. Ease: Just complete a simple enrollment form and include a prescription for ZOLINZA. Fast response: ZOLINZA can be shipped directly to your home within 48 to 72 hours of receipt of the enrollment form, unless your doctor would like your prescription for ZOLINZA to be sent to his or her office. Refills: A single enrollment form covers 1 prescription and refills. You can begin the prescription refill process with a simple call to 1-866-363-6379. * Individuals who have insurance still may qualify for Patient Assistance if both they and their physicians attest that the patients have special circumstances of financial and medical hardship and their income is not above a set upper limit. 5

ACT Now: 1-866-363-6379 Patient Assistance for Eligible Patients Who Is Qualified? You may obtain patient assistance through the ACT Program if you have been prescribed ZOLINZA (vorinostat) and all 3 of the following conditions apply: You live in the United States (you do not have to be a US citizen) and have a prescription for ZOLINZA from a doctor licensed in the United States. AND You do not have insurance or other coverage options for ZOLINZA.* Your dedicated Program Specialist will ensure that all alternate sources for reimbursement coverage such as private insurance, HMOs, Medicaid, Medicare, state pharmacy assistance programs, veterans assistance, or any other social service agency have been exhausted. AND You cannot afford to pay for ZOLINZA. Your Program Specialist will determine if you qualify for ZOLINZA free of cost on the basis of established criteria and your unique financial situation. * Individuals who have insurance still may qualify for Patient Assistance if both they and their physicians attest that the patients have special circumstances of financial and medical hardship and their income is not above a set upper limit. 6

How Do You Apply for Patient Assistance? You can start the Patient Assistance enrollment process by phone, by fax, or by mail. Phone Simply call 1-866-363-6379, 8 AM to 8 PM ET, Monday through Friday, and a Program Specialist will begin the enrollment process. Fax STEP 1: Complete and sign the enclosed enrollment form (available in the back pocket of this brochure or at zolinza.com). Remember that the appropriate sections of the enrollment form must be completed and that both you and your doctor must sign the form. Your prescription for ZOLINZA also must be forwarded to the ACT program. Incomplete or incorrectly completed forms will slow down the processing of your request. STEP 2: To ensure shipment of ZOLINZA to qualified patients within 48 to 72 hours, fax the completed form to 1-866-363-6389. Your physician's office must fax your prescription. After faxing the completed enrollment form, promptly enclose the signed original form and your prescription for ZOLINZA in the self-addressed, stamped envelope and mail it. Signed original enrollment forms and prescriptions for ZOLINZA must be received for all patients who receive ZOLINZA through the Patient Assistance Program. The first shipment will be made to approved patients on receipt of the faxed enrollment form; however, refills will not be shipped until we receive the original signed enrollment form. 7

ACT Now: 1-866-363-6379 Patient Assistance for Eligible Patients How Do You Apply for Patient Assistance? Mail Remember, if you do not have access to a fax machine, you may mail the signed original form (please include original prescription for ZOLINZA [vorinostat]). Once you have a completed and signed enrollment form, simply fold it, include your original prescription for ZOLINZA, seal it in the postage-paid envelope, and mail it to the following address: ACT PO Box 18979 Louisville, KY 40261-0979 Your ZOLINZA will be shipped 48 to 72 hours after we receive your completed enrollment form and prescription. 8

Other Important Information ZOLINZA that is distributed through the ACT program is free of charge to all eligible patients. Merck & Co., Inc., is not associated with any individuals or organizations that may charge patients a fee for helping them complete enrollment forms for our program. These individuals or organizations are acting independently of Merck, have no affiliation with Merck, and do not have the consent of Merck. Although Merck will make every effort to grant assistance, Merck cannot guarantee product patient assistance. Merck reserves the right to change or discontinue the program at any time. For additional information about ZOLINZA, please read the Patient Product Information enclosed with this brochure and ask your doctor for the physician Prescribing Information. 9

ACT Now: 1-866-363-6379 Notes: Name of your Program Specialist: (Telephone No.) 10

Notes: 11

ACT Now: 1-866-363-6379 Notes: 12

ACT Now: 1-866-363-6379 The ACT Program: Coordinates quick and convenient access to ZOLINZA (vorinostat). Assists you with your insurance coverage questions Provides ZOLINZA free of charge to eligible patients Can supply patient education materials and refill reminders ACT Now: Call 1-866-363-6379 Monday through Friday, 8 AM to 8 PM ET Log on to zolinza.com Brought to you by Merck & Co., Inc. ZOLINZA is a trademark of Merck & Co., Inc. Copyright 2006 Merck & Co., Inc. All rights reserved. 20606848(1)-10/06-ZOL

Patient Information ZOLINZA (zo LINZ ah) (vorinostat) Capsules Read the patient information that comes with ZOLINZA * before you start taking it and each time you get a refill. There may be new information. This leaflet is a summary of the information for patients. Your doctor or pharmacist can give you additional information. This leaflet does not take the place of talking with your doctor about your medical condition or your treatment. What is ZOLINZA? ZOLINZA is a prescription medicine used to treat a type of cancer called cutaneous T-cell lymphoma (CTCL) in patients when the CTCL gets worse, does not go away, or comes back after treatment with other medicines. ZOLINZA has not been studied in children under the age of 18. What should I tell my doctor before taking ZOLINZA? Tell your doctor about all of your medical conditions, including if you: Have any allergies Have had a blood clot in your lung (pulmonary embolus) Have had a blood clot in a vein (a blood vessel) anywhere in your body (deep vein thrombosis) Have nausea, vomiting, or diarrhea Have high blood sugar or diabetes Have heart problems Are pregnant or plan to become pregnant. ZOLINZA may harm your unborn baby. ZOLINZA has not been studied in pregnant women. If you use ZOLINZA during pregnancy, tell your doctor immediately. Are breast-feeding or plan to breast-feed. It is not known if ZOLINZA will pass into your breast milk. Talk to your doctor about the best way to feed your baby while you are taking ZOLINZA. Tell your doctor about all of the medicines you take, including prescription and non-prescription medicines, vitamins and herbal supplements. Some medicines may affect how ZOLINZA works, or ZOLINZA may affect how your other medicines work. Especially tell your doctor if you take: Valproic acid: a medicine used to treat seizures. Your doctor will decide if you should continue to take valproic acid and may want to test your blood more frequently. COUMADIN : (warfarin) or any other blood thinner. Ask your doctor if you are not sure if you are taking a blood thinner. Your doctor may want to test your blood more frequently. Know the medicines you take. Keep a list of your medicines and show it to your doctor and pharmacist when you get a new medicine. How should I take ZOLINZA? Take ZOLINZA exactly as your doctor tells you to. Your doctor will tell you how many ZOLINZA capsules to take and when to take them. Swallow each capsule whole. Do not chew or break open the capsule. If you can t swallow ZOLINZA * Trademark of Merck & Co., Inc., Whitehouse Station, New Jersey, 08889 USA COPYRIGHT 2006 MERCK & CO., Inc. All rights reserved

capsules whole, tell your doctor. You may need a different medicine. Take ZOLINZA with food. If ZOLINZA capsules are accidentally opened or crushed, do not touch the capsules or the powder contents of the capsules. If the powder from an open or crushed capsule gets on your skin or in your eyes, wash the contacted area well with plenty of plain water. Call your doctor. Drink at least eight 8-ounce glasses of liquids every day while taking ZOLINZA. Drinking enough fluids may help to decrease the chances of losing too much fluid from your body (dehydration) especially if you are having symptoms such as nausea, vomiting or diarrhea while taking ZOLINZA. If you miss a dose, take it as soon as you remember. If you do not remember until it is almost time for your next dose, just skip the missed dose. Just take the next dose at your regular time. Do not take two doses of ZOLINZA at the same time. If you take too much ZOLINZA, call your doctor, local emergency room, or poison control center right away. Your doctor will check your blood cell counts, blood sugar, and other chemistries every two weeks for the first two months of your treatment with ZOLINZA and then monthly. Your doctor may decide to do other tests to check your health as needed. If you have high blood sugar (hyperglycemia) or diabetes, continue to monitor your blood sugar as your doctor tells you to. Your doctor may need to change your diet or medicine to help control your blood sugar while you take ZOLINZA. Be sure to tell your doctor if you are unable to eat or drink normally due to nausea, vomiting or diarrhea. What are the possible side effects of ZOLINZA? ZOLINZA may cause serious side effects. Tell your doctor right away if you have any of the following symptoms: Blood clots in the legs (deep vein thrombosis) sudden swelling in a leg pain or tenderness in the leg. The pain may only be felt when standing or walking. increased warmth in the area where the swelling is. skin redness or change in skin color Blood clots that travel to the lungs (pulmonary embolus) sudden sharp chest pain rapid pulse shortness of breath fainting cough with bloody secretions feeling anxious sweating Dehydration (loss of too much fluid from the body). This can happen if you are having nausea, vomiting or diarrhea and can not drink fluids well. Low blood cell counts: Your doctor will periodically do blood tests to check your blood counts. Low red blood cells. Low red blood cells may make you feel tired and get tired easily. You may look pale, and feel short of breath. Low platelets. Low platelets can cause unusual bleeding or bruising under the skin. Talk to your doctor right away if this happens. High blood sugar (blood glucose). If you have high blood sugar or diabetes, monitor your blood sugar frequently as directed by your doctor. Tell your doctor right away if your blood sugar is higher than normal. Electrocardiogram abnormality. An electrocardiogram, or EKG, is a test that records the electrical 2

activity of your heart. Your doctor will check your blood electrolytes and electrocardiogram periodically. In addition, the most common side effects with ZOLINZA include: Stomach and intestinal problems, including diarrhea, nausea, vomiting, loss of appetite, constipation and weight loss Tiredness Dizziness Headache Changes in the way things taste and dry mouth Muscle aches Hair loss Chills Fever Upper respiratory infection Cough Increase in blood creatinine Swelling in the foot, ankle and leg Itching Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of ZOLINZA. For more information, ask your doctor or pharmacist. General information about ZOLINZA Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use ZOLINZA for a condition for which it was not prescribed. Do not give ZOLINZA to other people, even if they have the same symptoms you have. It may harm them. Keep ZOLINZA and all medicines out of the reach of children. This leaflet summarizes the most important information about ZOLINZA. If you would like to know more information, talk to your doctor. You can ask your doctor or pharmacist for information about ZOLINZA that is written for health professionals. What are the ingredients in ZOLINZA? Active ingredient: vorinostat Inactive ingredients: microcrystalline cellulose, sodium croscarmellose and magnesium stearate. The inactive ingredients in the capsule shell are titanium dioxide, gelatin, and sodium lauryl sulfate. How should I store ZOLINZA? Store ZOLINZA at room temperature, 68 o F to 77 o F (20 o C to 25 o C). Issued: October 2006 MERCK & CO., INC. Whitehouse Station, NJ 08889, USA 9762600 3